First, I'm going to ask three things: Please read this. Please share this. Please get the book. Because, what you will find within its pages will give you hope (because you did not know this information before), will make you incredibly broken hearted (because you did not know this information before) and will make you righteously angry (because you did not know this information before).
The following is an excerpt from the book, Surviving Cancer Covid-19 & Disease The Repurposed Drug Revolution by Justus R. Hope. M.D.:
"As in any repurposed drug discussion, it is always the scientist versus the regulators; it boils down to the doctors versus Big Pharma. Here the scientists are led by Dr. Didier Raoult, the Dr. Pan Pantziarka of the anti-coronavirus movement, who brings the spotlight to the effectiveness of HCQ and CQ against SARS-CoV-2. Raoult, a larger than life medical luminary physician and professor, is the top expert in the world in communicable disease........
Professor Raoult completed residencies in both internal medicine and infectious disease and earned both MD and PhD degrees.......
He has been referred to as the most productive and cited microbiologist in Europe. He directs the IHU Mediterranean Infection Institute in Marseille, France, a world-renowned research and teaching center dedicated to the management and study of infectious disease. Dr. Didier Raoult, both controversial and outspoken, is one of the world's most influential and productive scientists. As of this writing, he is listed as either the author or coauthor of 2,909 Pubmed citations.
He is also the antithesis of Dr. Anthony Fauci or any regulatory body. So, when Dr. Raoult published his landmark HCQ study, the first detailed human trial to show the benefit of hydroxychloroquine and chloroquine and those afflicted with COVID-19, he ignited a firestorm. Chloroqine and hydroxychloroquine were long known to block both cell entry and replication in SARS and MERS. They should also work well against SARS-CoV2.
However, these early studies were confined to lab testing only, testing the activity of these drugs in the test tube. Didier was among the first, along with the Chinese, to show that HCQ worked in live human subjects with coronavirus infections. But the Chinese declined to produce their data.
Didier, on the other hand, was quick to unveil stunning results. In his pilot study, he treated 20 infected patients with hydroxychloroquine and compared them with 16 infected controls that were not treated.* By the third day, 50% of the treated group were negative for the virus. By the sixth day, 70% of the hydroxyhloroquine group were viral negative.
Six of the 20 patients were treated with Zithromax in addition to hydroxychloroquine. Most impressively, these six patients tested 100% negative for the virus on day six. Only 12.5% of the non treated group, however, was virus free. These results suggested a 100% cure rate for the group receiving the hydroxychloroquine and Zithromax by day six compared with a 90% infection rate for the group untreated.
For reference, the Chinese had already shown that untreated COVID-19 patients could remain infectious for some 19-20 days; in some cases, up to 34 days.* Dr. Raoult felt that the information contained in his study was so significant, that he was ethically bound to release the results immediately, prior to the usual peer-review process. Dr. Raoult recommended that COVID-19 patients be treated with hydroxychloroquine and azithromycin to both cure their infection and to curb the spread. He freely admitted that although better and more scientific therapy, such as a specific vaccine, might later be developed, the current treatment was imminently necessary to treat the COVID-19 threat in real time.
By eradicating the virus at day 6, Raoult had shortened the time for contagiousness by 66% from 19 days to only six. The implications were staggering. If his results held up, that meant quarantines and isolation times could end 70% sooner. It meant quicker recovery times in infected patients. It also implied lower rates of death. It meant health care workers could take the drug preventatively and not pass the virus to patients. Dr. Raoult had given the world a gift, a crucial tool to stem the pandemic, a discovery worthy of a Nobel prize.
Raoult and his colleagues wrote, "We therefore recommend that COVID-19 patients be treated with hydroxyholorquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of COVID-19 in the world. Further works are also warranted to determine if these compounds could be useful as chemoprophylaxis to prevent the transmission of the virus, especially for healthcare workers."*
Raoult's study found what the CDC researchers working on test tubes in 2005 had strongly suspected. Chloroquine and hydroxychloroquine might work against the coronavirus in vivo just as well as in vitro, in life just as well as in the lab; it might just be the answer to SARS-CoV2 and the pandemic: a repurposed drug that might attack not only cancer but also the novel coronavirus.
DR. Fauci's Reaction
Here we had the result of an open-label non-randomized clinical trial involving 36 patients studied with a drug the CDC knew killed the SARS virus. How would the US task force respond? On March 20, 2020, I watched as they commented on the news. The head of the NIAH had one word.
"Anecdotal."
Without so much as a blink, I stared at the television in disbelief. I replayed the recording to make sure I had heard correctly......."
* reference numbers in the book, linked to the original studies.
I know, it is hard to believe that sources, we have been programmed to trust, would intentionally keep vital information from us, but this is exactly what has been going on. Please, take the time to do some research on your own. Don't sit and be spoon fed. If not for yourself, for all the people who have suffered or been lost, because they did not know this information before.
No comments:
Post a Comment